Literature DB >> 25082185

Multidrug-resistant (MDR) Aeromonas recovered from the metropolitan area of Valencia (Spain): diseases spectrum and prevalence in the environment.

C Esteve1, E Alcaide2, M J Giménez3.   

Abstract

Aeromonas infections are rare in Europe and often related to traveller's diarrhoea. A total of 185 Aeromonas isolates from river water, fish and clinical sources, recovered during a 1-year period, were used to investigate the disease spectrum and impact of multidrug-resistant (MDR) strains. They were all identified by biochemical tests and 25% of them were also identified by sequencing of the 16S rRNA gene. The minimum inhibitory concentrations (MICs) of 21 antimicrobials were determined for all isolates by broth microdilution/E-strips methods, and susceptibility was assessed according to the Clinical and Laboratory Standards Institute (CLSI). Strains pathogenicity was determined by using Swiss Webster mice as the animal model. Aeromonas diseases had an incidence of around 20 cases/million inhabitants in the metropolitan area of Valencia (Spain). Acute gastroenteritis in children with no history of travel abroad was the main pathology. These cases were related to A. caviae, A. veronii biovar sobria, A. hydrophila and A. dhakensis. A significant incidence of A. caviae in humans was found, while the other species were equally present in clinical and environmental origins. A. jandaei, A. bestiarum and A. media had mainly an environmental distribution. The prevalence of MDR Aeromonas was maximal in clinical samples, and resistance phenotypes were significantly related to this source. 7.2% of environmental Aeromonas was resistant to at least five drugs; most of them were moderately virulent for mice and, in addition, belonged to clinically significant species. The present study demonstrates a diseases spectrum similar to that reported in tropical countries, and also that pathogenic and heavily MDR Aeromonas are present in environmental reservoirs. MDR Aeromonas from any source analysed were susceptible to aztreonam, netilmicin, cefotaxime, ceftazidime, cefepime and fluoroquinolones.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25082185     DOI: 10.1007/s10096-014-2210-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  37 in total

1.  Antimicrobial resistance of mesophilic Aeromonas spp. isolated from two European rivers.

Authors:  M Goñi-Urriza; L Pineau; M Capdepuy; C Roques; P Caumette; C Quentin
Journal:  J Antimicrob Chemother       Date:  2000-08       Impact factor: 5.790

2.  Microbes have the last word. A drastic re-evaluation of antimicrobial treatment is needed to overcome the threat of antibiotic-resistant bacteria.

Authors:  Julian Davies
Journal:  EMBO Rep       Date:  2007-07       Impact factor: 8.807

3.  In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.

Authors:  Chia-Ying Liu; Yu-Tsung Huang; Chun-Hsing Liao; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

Review 4.  Epidemiology of resistance to antibiotics. Links between animals and humans.

Authors:  A E van den Bogaard; E E Stobberingh
Journal:  Int J Antimicrob Agents       Date:  2000-05       Impact factor: 5.283

5.  Typing of Aeromonas strains from patients with diarrhoea and from drinking water.

Authors:  A H Havelaar; F M Schets; A van Silfhout; W H Jansen; G Wieten; D van der Kooij
Journal:  J Appl Bacteriol       Date:  1992-05

6.  Antimicrobial resistance survey in a river receiving effluents from freshwater fish farms.

Authors:  L Gordon; E Giraud; J-P Ganière; F Armand; A Bouju-Albert; N de la Cotte; C Mangion; H Le Bris
Journal:  J Appl Microbiol       Date:  2007-04       Impact factor: 3.772

7.  beta-Lactam resistance of motile Aeromonas isolates from clinical and environmental sources.

Authors:  K Morita; N Watanabe; S Kurata; M Kanamori
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

8.  Incidence of haemolysin-positive and drug-resistant Aeromonas hydrophila in freshly caught finfish and prawn collected from major commercial fishes of coastal South India.

Authors:  Tha Thayumanavan; G Vivekanandhan; K Savithamani; R Subashkumar; P Lakshmanaperumalsamy
Journal:  FEMS Immunol Med Microbiol       Date:  2003-05-15

9.  Phylogenetic interrelationships of members of the genera Aeromonas and Plesiomonas as determined by 16S ribosomal DNA sequencing: lack of congruence with results of DNA-DNA hybridizations.

Authors:  A J Martinez-Murcia; S Benlloch; M D Collins
Journal:  Int J Syst Bacteriol       Date:  1992-07

10.  Prevalence, serotype distribution, antibiotic susceptibility and genetic profiles of mesophilic Aeromonas species isolated from hospitalized diarrhoeal cases in Kolkata, India.

Authors:  S Sinha; T Shimada; T Ramamurthy; S K Bhattacharya; S Yamasaki; Y Takeda; G Balakrish Nair
Journal:  J Med Microbiol       Date:  2004-06       Impact factor: 2.472

View more
  10 in total

1.  Detection and Whole-Genome Sequencing of Carbapenemase-Producing Aeromonas hydrophila Isolates from Routine Perirectal Surveillance Culture.

Authors:  Heather Y Hughes; Sean P Conlan; Anna F Lau; John P Dekker; Angela V Michelin; Jung-Ho Youn; David K Henderson; Karen M Frank; Julia A Segre; Tara N Palmore
Journal:  J Clin Microbiol       Date:  2016-02-17       Impact factor: 5.948

2.  Clinical features and outcome of Aeromonas sobria bacteremia in pediatric and adult patients with hematologic malignancies: A single-center retrospective study in Peru.

Authors:  Bryan Valcarcel; Gabriel De-la-Cruz-Ku; Luis Malpica; Daniel Enriquez-Vera
Journal:  PLoS One       Date:  2021-08-11       Impact factor: 3.240

3.  Use of Aeromonas spp. as General Indicators of Antimicrobial Susceptibility among Bacteria in Aquatic Environments in Thailand.

Authors:  Masaru Usui; Chie Tagaki; Akira Fukuda; Torahiko Okubo; Chanchai Boonla; Satoru Suzuki; Kanako Seki; Hideshige Takada; Yutaka Tamura
Journal:  Front Microbiol       Date:  2016-05-12       Impact factor: 5.640

Review 4.  The Social Life of Aeromonas through Biofilm and Quorum Sensing Systems.

Authors:  Emilie Talagrand-Reboul; Estelle Jumas-Bilak; Brigitte Lamy
Journal:  Front Microbiol       Date:  2017-01-20       Impact factor: 5.640

5.  Distinct Aeromonas Populations in Water Column and Associated with Copepods from Estuarine Environment (Seine, France).

Authors:  Gautier Chaix; Frédéric Roger; Thierry Berthe; Brigitte Lamy; Estelle Jumas-Bilak; Robert Lafite; Joëlle Forget-Leray; Fabienne Petit
Journal:  Front Microbiol       Date:  2017-07-11       Impact factor: 5.640

6.  Occurrence and Variety of β-Lactamase Genes among Aeromonas spp. Isolated from Urban Wastewater Treatment Plant.

Authors:  Marta Piotrowska; Dominika Przygodzińska; Klaudia Matyjewicz; Magdalena Popowska
Journal:  Front Microbiol       Date:  2017-05-16       Impact factor: 5.640

7.  Clinical significance and outcome of Aeromonas spp. infections among 204 adult patients.

Authors:  J Nolla-Salas; J Codina-Calero; S Vallés-Angulo; A Sitges-Serra; A Zapatero-Ferrándiz; M C Climent; J Gómez; J R Masclans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-03       Impact factor: 3.267

8.  Molecular Characterization of Ahp2, a Lytic Bacteriophage of Aeromonas hydrophila.

Authors:  Jian-Bin Wang; Mei-Shiuan Yu; Tsai-Tien Tseng; Ling-Chun Lin
Journal:  Viruses       Date:  2021-03-14       Impact factor: 5.048

9.  Prediction and Analysis in silico of Genomic Islands in Aeromonas hydrophila.

Authors:  Antonio Camilo da Silva Filho; Jeroniza Nunes Marchaukoski; Roberto Tadeu Raittz; Camilla Reginatto De Pierri; Diogo de Jesus Soares Machado; Cyntia Maria Telles Fadel-Picheth; Geraldo Picheth
Journal:  Front Microbiol       Date:  2021-11-29       Impact factor: 5.640

Review 10.  Colistin Resistance in Aeromonas spp.

Authors:  Luis Uriel Gonzalez-Avila; Miguel Angel Loyola-Cruz; Cecilia Hernández-Cortez; Juan Manuel Bello-López; Graciela Castro-Escarpulli
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.